Adverse events of special interest (AESIs) collected for all participants;Number of participants (baseline persons living with HIV [PLWH] and SARS-CoV-2 negative) with COVID-19;Number of participants (baseline PLWH and SARS-CoV-2 negative) with severe COVID-19;Serious adverse events (SAEs) collected for all participants;Solicited Adverse events for a subset of participants;Unsolicited adverse events collected for a subset of participants

Adverse events of special interest (AESIs) collected for all participants;Number of participants (baseline persons living with HIV [PLWH] and SARS-CoV-2 negative) with COVID-19;Number of participants (baseline PLWH and SARS-CoV-2 negative) with severe COVID-19;Serious adverse events (SAEs) collected for all participants;Solicited Adverse events for a subset of participants;Unsolicited adverse events collected for a subset of participants